$Avalo Therapeutics (AVTX.US)$ stock is rocketing higher on Thursday after announcing a couple of positive updates for investors in the clinical-stage biotechnology company.
The first big update worth noting is the company securing $185 million through a private placement. This funding comes from an agreement with institutional investors.
The private placement includes $115.6 million of non-voting convertible preferred stock and warrants worth another $69.4 million...